PATENT CLAIM ANALYSIS

Application Number: 16100105
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-07
Patent Classification: ["514", "004800"]

Abstract:
The invention provides methods of preventing or treating metabolic syndrome in a mammalian subject. The methods comprise administering to the subject an effective amount of an aromatic-cationic peptide to subjects in need thereof.

Claim (Index 12):
The method of  claim 1 , wherein the peptide is administered prior to the onset of type II diabetes.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 96.0
- Lexical Diversity: 1.2963
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13897070', '14671538', '15401527', '12367267', '12392565']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7881159067444414
- 35 USC 102 Novelty (BERT): 0.52657555063915
- Combined Prediction Score: 0.7619618711339123
- Mean Citation Score: 333.911284
- Max Citation Score: 342.51965
- Similarity Product: 295.21473686168787

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test